Award recordCONTRACT

PFIZER INC

PIID 36E79720D0067· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2020· $0 net obligations· UEI MHBQULRMEEJ5· NY

Description

PUBLIC LAW UPDATES

Base award description: NEW AWARD FOR EPOETIN VIALS WITH PFIZER INC. PERIOD OF PERFORMANCE IS 10/08/2020 - 10/07/2021 WITH FOUR ONE-YEAR OPTION PERIODS.

First action · last action
2020-09-11 · 2024-12-27
Transactions
17
First transaction's obligation
$0
Base + all options value (sum of deltas)
$66,935,446
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 17 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2020-09-11 · this action $0 · running total $0Modification P00001 · 2021-01-07 · this action $0 · running total $0Modification P00002 · 2021-03-30 · this action $0 · running total $0Modification P00003 · 2021-09-15 · this action $0 · running total $0Modification P00004 · 2021-12-30 · this action $0 · running total $0Modification P00005 · 2022-07-01 · this action $0 · running total $0Modification P00007 · 2022-09-20 · this action $0 · running total $0Modification P00008 · 2023-01-04 · this action $0 · running total $0Modification P00009 · 2023-01-04 · this action $0 · running total $0Modification P00010 · 2023-05-15 · this action $0 · running total $0Modification P00011 · 2023-09-19 · this action $0 · running total $0Modification P00012 · 2023-10-17 · this action $0 · running total $0Modification P00013 · 2023-12-26 · this action $0 · running total $0Modification P00014 · 2024-02-05 · this action $0 · running total $0Modification P00015 · 2024-04-11 · this action $0 · running total $0Modification P00016 · 2024-10-02 · this action $0 · running total $0Modification P00017 · 2024-12-27 · this action $0 · running total $0
  • Base2020-09-11+$0= $0
  • Mod P000012021-01-07+$0= $0
  • Mod P000022021-03-30+$0= $0
  • Mod P000032021-09-15+$0= $0
  • Mod P000042021-12-30+$0= $0
  • Mod P000052022-07-01+$0= $0
  • Mod P000072022-09-20+$0= $0
  • Mod P000082023-01-04+$0= $0
  • Mod P000092023-01-04+$0= $0
  • Mod P000102023-05-15+$0= $0
  • Mod P000112023-09-19+$0= $0
  • Mod P000122023-10-17+$0= $0
  • Mod P000132023-12-26+$0= $0
  • Mod P000142024-02-05+$0= $0
  • Mod P000152024-04-11+$0= $0
  • Mod P000162024-10-02+$0= $0
  • Mod P000172024-12-27+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2020-09-11+$0$0NEW AWARD FOR EPOETIN VIALS WITH PFIZER INC. PERIOD OF PERFORMANCE IS 10/08/2020 - 10/07/2021 WITH FOUR ONE-Y…
Mod P00001· OTHER ADMINISTRATIVE ACTION2021-01-07+$0$0EPOETIN FCP PRICE (NO CHANGE) MODIFICATION.
Mod P00002· ADD SUBCONTRACTING PLAN2021-03-30+$0$02021 SUBCONTRACTING PLAN
Mod P00003· EXERCISE AN OPTION2021-09-15+$0$0EXERCISE OPTION 1 WITH NO PRICE CHANGES.
Mod P00004· OTHER ADMINISTRATIVE ACTION2021-12-30+$0$0FEDERAL CEILING PRICE MODIFICATION - NO CHANGE IN PRICE.
Mod P00005· ADD SUBCONTRACTING PLAN2022-07-01+$0$02022 SUBCONTRACTING PLAN FOR 36E79720D0067 PFIZER
Mod P00007· EXERCISE AN OPTION2022-09-20+$0$0EXERCISE OPTION 2 ON CONTRACT 36E79720D0067 WITH NO PRICE CHANGES
Mod P00008· ADD SUBCONTRACTING PLAN2023-01-04+$0$0SUBCONTRACTING PLAN 2023
Mod P00009· OTHER ADMINISTRATIVE ACTION2023-01-04+$0$0MODIFICATION TO INCORPORATE THE 2023 FCPS. NO CHANGE IN AWARDED NATIONAL CONTRACT PRICES.
Mod P00010· OTHER ADMINISTRATIVE ACTION2023-05-15+$0$0ADD DSCSA LANGUAGE.
Mod P00011· EXERCISE AN OPTION2023-09-19+$0$0EXERCISE OPTION 3 WITH NO PRICE CHANGES.
Mod P00012· ENTITY ADDRESS CHANGE2023-10-17+$0$0PFIZER NAME AND ADDRESS CHANGE.
Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-12-26+$0$02024 PUBLIC LAW UPDATES
Mod P00014· ADD SUBCONTRACTING PLAN2024-02-05+$0$0INCORPORATE 2024 PFIZER SUBCONTRACTING PLAN
Mod P00015· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-04-11+$0$0CRF SUBMITTAL AND REPORTING CHANGES
Mod P00016· EXERCISE AN OPTION2024-10-02+$0$0EXERCISE OPTION YEAR 4 - EPOETIN - PFIZER - 36E79720D0067 WITH NO PRICE CHANGES
Mod P00017· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-12-27+$0$0PUBLIC LAW UPDATES

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI MHBQULRMEEJ5)

AwardOffice · PSC / listingNet obligationsFY
36E79725D0032NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36E79725D0030NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36C77024P0393NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$243,101FY2024
36F79724D0130NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C25024F0047250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$215,205FY2024
36E79723A0023NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79720D0067_3600 · retrieved 2026-09-26.